Official Summary Text
Present law authorizes the attorney general, upon written approval of the governor and comptroller of the treasury, to release any pending or future claim of governmental entities against McKesson, Cardina
l Health, AmerisourceBergen, Johnson & Johnson, Allergan Finance, CVS, Teva Pharmaceuticals, Walgreens, Walmart, K-VA-T Food Stores, and Kroger in such entities' settlement agreements for activities related to the manufacture, marketing, distribution, dis
p
ensing, or sale of opioids, if the attorney general deems the release necessary to the interest of the state in the resolution of the opioid crisis. This bill adds to the list of entities authorized for release Amneal Pharmaceuticals, Hikma Pharmaceutica
l
s, and Sun Pharmaceutical Industries.
For proceeds received from a statewide opioid settlement agreement with McKesson, Cardinal Health, AmerisourceBergen, Johnson & Johnson, Allergan Finance, CVS, Teva Pharmaceuticals, Walgreens, Walmart, K-VA-T Food St
ores, or Kroger, present law requires the Tennessee opioid abatement council to disburse 35% of these proceeds to counties that join the settlement and 65% for statewide, regional, or local opioid abatement and remediation purposes. This bill adds to suc
h
funds proceeds from a settlement agreement with Amneal Pharmaceuticals, Hikma Pharmaceuticals, or Sun Pharmaceutical Industries.
ON MARCH 10, 2025, THE SENATE ADOPTED AMENDMENT #1 AND PASSED SENATE BILL 48, AS AMENDED.
AMENDMENT #1 makes the following
revisions:
A
dds to the list of entities authorized for release
Indivior Inc.
,
Viatris Inc., and Purdue Pharma L.P.
A
dds to funds proceeds from a settlement agreement with
Indivior Inc.
,
Viatris Inc., and Purdue Pharma L.P.
Applies the bill, in addition to settlement agreements
for activities related to the manufacture, marketing, distribution, dispensing, or sale of opioids
, to a
bankruptcy plan and related agreements
to such activities.
Current Bill Text
Read the full stored bill text
SENATE BILL 48
By Haile
HOUSE BILL 491
By Farmer
HB0491
001063
- 1 -
AN ACT to amend Tennessee Code Annotated, Title 20
and Title 33, relative to opioids.
BE IT ENACTED BY THE GENERAL ASSEMBLY OF THE STATE OF TENNESSEE:
SECTION 1. Tennessee Code Annotated, Section 20-13-203, is amended by deleting
the language "and The Kroger Co." wherever it appears and substituting instead the language
"The Kroger Co., Amneal Pharmaceuticals LLC, Hikma Pharmaceuticals USA Inc., and Sun
Pharmaceutical Industries, Inc.".
SECTION 2. Tennessee Code Annotated, Section 33-11-103(p), is amended by
deleting the language "or The Kroger Co." and substituting instead the language "The Kroger
Co., Amneal Pharmaceuticals LLC, Hikma Pharmaceuticals USA Inc., or Sun Pharmaceutical
Industries, Inc.".
SECTION 3. If any provision of this act or its application to any person or circumstance
is held invalid, then the invalidity does not affect other provisions or applications of the act that
can be given effect without the invalid provision or application, and to that end, the provisions of
this act are severable.
SECTION 4. This act takes effect upon becoming a law, the public welfare requiring it.